Saturday, May 4 2024 | Time 00:36 Hrs(IST)
image
Business Economy


Study says- Respiratory Ailments are the 2nd Highest cause of death in India

MUMBAI, India, Oct 5, 2021 /PRNewswire/ -- According to the University of Washington's Global Burden of Disease study, respiratory disease was the second highest cause of death in India after heart disease, killing 1 million Indians in 1 year.

Winter brings with it an inverted atmosphere that causes respiratory symptoms, including dry cough, wheeze, chest discomfort and attacks of breathlessness. I

n addition to poor air quality, the COVID 19-Pandemic has also made us more aware of the importance of our lung health.

According to a study published in The Lancet Global Health, there were 28.1 million cases of respiratory diseases in India in 1990, which has increased to 55.3 million in recent years. India has 18% of the world's population but 32% of its respiratory diseases burden. Each of us has been touched by these illnesses, be it seeing our kids, parents or other near and dear ones gasping for breath.

For Photos Click the links below:

https://www.drbatras.com/themes/drbatra/images/company/drmukeshbatra.jpg

https://www.drbatras.com/images/press-release/lung-function-test-spirometer.jpg

Dr Batra's Healthcare introduces Oxylung – a comprehensive lung health treatment programme which includes the Lung Function Test and Homeopathic Nebulization. The Lung Function Test - a hospital grade, accurate and scientific test that is computerized, painless, and will help patients assess their lung's strength, volume and breathing capacity.

Conventional steroidal nebulizers are known to cause side effects like a sore mouth, nosebleeds and oral thrush (infections that can have long lasting and damaging affects for children and adults).

Dr Batra's Homeopathic Nebulizer administers homeopathic medicines in a safe, natural and side effect free way. Patients with respiratory allergies can now breath easy with Dr Batra's Homeopathic Nebulizer - a device that quickly administers homeopathic medicines to give faster and augmented results in a natural and side-effect free way. The nebulizer helps the homeopathic medicine reach directly to the airways to treat respiratory problems faster and more effectively.

Commenting on the launch of Oxylung, Dr. Mukesh Batra, Padma Shri recipient & Founder, Dr Batra's Healthcare said, "Homeopathy has proven efficacy in treating respiratory conditions the natural way. We have always been at the forefront of bringing scientific and measurable homeopathy to bring about better treatment outcomes. Our expert homeopathic specialists have curated a respiratory treatment solution that is painless, offers measurable results and gives computerized reports about your lung health. During these covid times, we aim to provide our patients with solutions that are helpful, effective and the need of the hour."

With lung health being integral to survival, why wait for winter to seek a resolution. Start the journey to easy breathing today. Get a FREE Lung Function test along with the first homeopathic respiratory consultation. Visit the nearest Dr Batra's clinic or call 9167791677 today.

About Dr Batra's Healthcare

With over 200 clinics in around 150 cities across 7 countries including India, UK, Estonia, UAE, and Greece, Dr Batra's Homeopathy Clinics have over 400 doctors including skin specialists, hair specialists, and experienced homeopathic doctors. Dr Batra's has treated over 1 million patients and been recognized as an 'Icon of Indigenous Excellence in Healthcare' by The Economic Times. Dr Batra's specializes in Hair, Skin, Allergies, Child and Women's Health, Mental Health, Sexual Health, and Weight Management ailments including Hair Loss, Vitiligo, Psoriasis, Acne, Low immunity, Tonsillitis, Stress Management, Migraine, Thyroid, PCOS, Menopause, Allergies, Infertility, and Impotence.

Sources

https://www.indiaspend.com/this-disease-is-the-2nd-highest-killer-of-indians-yet-doctors-or-patients-do-not-know-enough-about-it/ https://www.ceew.in/publications/delhi-winter-pollution-control-measureshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612296/ https://www.indiaspend.com/why-india-is-struggling-to-tackle-its-pulmonary-disease-crisis/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766284/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800767/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513633/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031196/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850165/https://www.premiermedicalhv.com/news/dealing-with-copd-in-winter/For more information, Contact:

Danielle Gracias

+91 9819180717

[email protected]

Website: https://www.drbatras.com/

(Disclaimer--Features may vary depending on the regions; subject to change without notice.)



Follow us on:

Facebook: https://www.facebook.com/DrBatrasHealthcare

Twitter: https://twitter.com/DrBatrasHealth

YouTube: https://www.youtube.com/channel/UCATPyDDMOHta9u8ffsRtt5A

Instagram: https://www.instagram.com/drbatras_healthcare/?hl=en

Logo: https://mma.prnewswire.com/media/846836/Dr_Batra_s_Homeopathy_Logo.jpg

More News

M&M leads Indian auto-pack with record-breaking 674 patents in FY24

03 May 2024 | 7:12 PM

Kolkata, May 3 (UNI) Mahindra & Mahindra (M&M), the automotive and farm equipment flagship of the Mahindra Group, has received a record 674 patents in FY24, the most of any Indian 4-wheeler automobile/farm equipment manufacturer.

see more..

MRF' s consolidated income Rs 25,486 cr in FY 2023-24

03 May 2024 | 7:00 PM

Chennai, May 3 (UNI) Tyre major MRF' s consolidated total income is Rs 25,486 Crores for the year ended March 31, 2024, as compared to Rs. 23,261 crores in the previous year.

see more..
Rs 2000 banknotes continue to be legal tender; 97 76% returned till now: RBI

Rs 2000 banknotes continue to be legal tender; 97 76% returned till now: RBI

03 May 2024 | 6:48 PM

Mumbai, May 3 (UNI) The Government has received 97.76 percent of Rs 2000 currency notes as on April 30, 2024, the RBI said on Friday while adding that the banknotes continue to be legal tender.

see more..

RXIL TReDS surpasses Rs 1 lakh cr in invoice financing for MSMEs

03 May 2024 | 6:23 PM

Mumbai, May 3 (UNI) Receivables Exchange of India Limited (RXIL) Trade Receivables Discounting System (TReDS) has achieved a significant milestone, facilitating financing of over 50 lac invoices worth Rs one lakh crore since its inception, providing accessible working capital financing solutions to Micro, Small and Medium Enterprises (MSMEs) in India which play a pivotal role in driving economic growth and facilitating the nation's journey towards achieving a Rs five trillion economy.

see more..
Profit booking pulls market down nearly 1%

Profit booking pulls market down nearly 1%

03 May 2024 | 6:11 PM

Mumbai, May 3 (UNI) The stock market on Friday fell nearly one percent as the BSE sensex closed at 73878.15 points down by 732.96 points from previous close even as there were no negative surprises in the Q4 earnings of some of major companies.

see more..
image